Modern Practice Podcast

The administrative burden – Part 1

For every hour a physician or clinician spends with a patient, they will spend at least another half hour or more on documentation or other administrative work. More than that, around 25 percent of the dollars spent in health care are on wasteful administrative tasks. Such a burden leads to long hours and takes the clinician away from patient interaction and care, continuing education, clinical decision-making and personal and family time. It can lead to burnout and worse. On this episode, a leading expert discusses the challenge of administrative burden and what practices and organizations can do to remedy it.
 
Guest speaker:
Nigel Girgrah, MD, PhD
Chief Wellness Officer
Ochsner Health System
Medical Director, Liver Transplantation
Ochsner Medical Center
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
 
Show Notes:
[01:20] The administrative burden
[02:11] EHRs, burnout and “pajama time”
[03:51] Toll on female clinicians
[04:26] Where clinician burnout can lead
[05:19] Craig’s story and the high risk of physician burnout
[07:14] A systems approach to well-being
[09:14] Drivers of professional fulfillment
[09:34] The Fourth Aim: caring for the caregivers
 
Links | Resources:
“Death by 1,000 Cuts” (Medscape) Click here
Craig McKinley article Click here
Reducing Administrative Waste in the US Health Care System (JAMA) Click here
Senator Cassidy and Dr. Lorna Breen Health Care Provider Protection Act Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Connecting with patients and families during COVID-19 – Part 3

On this episode, we conclude our three-part series detailing patient and family concerns as the pandemic heads into its second year. Based on Vizient’s extensive and ongoing assessments, we have learned how patients and families feel about COVID testing and vaccines, from where they prefer receiving their tests to whether or not they plan to take a vaccine at all. This information will be valuable for bringing patient and family desires into your care planning and care approaches in the near future.
 
Guest speaker:
Kellie Goodson, MS, CPXB
Performance Improvement Program Director
Vizient
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
 
Show Notes:
[00:20] Patient and family attitudes toward testing
[01:26] Attitudes toward testing locations
[02:15] COVID Vaccines
[03:56] Vaccine locations
[05:58] Trust in providers
[08:42] Value in listening to patients and families
 
Links | Resources:
Summary Report – Connecting with Patients During COVID-19: Perspectives on Safety Click here
AAMC-Vizient White Paper on patient-centered care Click here
Patient and Family-Centered Care: A Systematic Approach (AMA Journal of Ethics) Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Connecting with patients and families during COVID-19 – Part 2

In this episode, we continue our discussion on patient and family engagement (PFE) and concerns as the pandemic continues. We will focus on accessing care, on the care settings patients and families prefer—whether virtual visits, urgent care, the ER or the caregiver’s office—and on their attitudes toward going in for preventative screenings, such as colonoscopies or mammograms. The extensive and ongoing assessment of patients and families by Vizient and Sg2 will yield valuable information for your clinical practice.
 
Guest speaker:
Kellie Goodson, MS, CPXB
Performance Improvement Program Director
Vizient
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
 
Show Notes:
[00:33] Preferences as to care settings
[02:20] Concerns for the next six months
[03:27] Preferences as to care after the pandemic
[05:17] Categories of patient and family respondents
[05:38] An opportunity for providers
[06:09] Preferences as to preventative screenings
[07:09] A personal example
 
Links | Resources:
Summary Report – Connecting with Patients During COVID-19: Perspectives on Safety Click here
AAMC-Vizient White Paper on patient-centered care Click here
Patient and Family-Centered Care: A Systematic Approach (AMA Journal of Ethics) Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Connecting with patients and families during COVID-19 – Part 1

Two of the most significant challenges facing clinical practices today, to increase patient satisfaction and to meet patient demands, involve connecting with patients and families. Recognizing patient and family engagement (PFE) as a critical aspect of care, especially as COVID-19 has overhauled and overwhelmed care delivery models, Vizient and Sg2 have conducted ongoing assessments of patients and families to learn their attitudes during this crisis. In this episode, part one of a three-part series, we will discuss those patient-family assessments and what they reveal.
 
Guest speaker:
Kellie Goodson, MS, CPXB
Performance Improvement Program Director
Vizient
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
 
Show Notes:
[01:02] Rationale for PFE
[02:34] New assessment approach for PFE through 2020-2021
[03:57] The main patient and family concern
[05:25] Attitudes toward elective procedures: a change for the worse
[09:21] Need for provider engagement
 
Links | Resources:
Summary Report – Connecting with Patients During COVID-19: Perspectives on Safety Click here
AAMC-Vizient White Paper on patient-centered care Click here
Patient and Family-Centered Care: A Systematic Approach (AMA Journal of Ethics) Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

What does transformation look like in the post-pandemic era? – Part 2

Drastic forces unleashed by COVID-19 have transformed everything, including health care. Clinical care delivery has changed. Health policies have changed. Regulation and payment have changed. Whether or not these changes will last is up in the air as the pandemic enters a second year. On this episode, part two of a series, Modern Practice brings back an expert who will look at what has happened and address questions and concerns about what will happen.
 
Guest speaker:Celina BurnsPrincipalFinancial Performance SolutionsVizient
 
Moderator:Tomas Villanueva, DO, MBA, FACPE, SFHMAssociate Vice PresidentClinical ResourcesVizient
 
Show Notes:[00:23] Acquisition, compensation and productivity[02:27] Hospital-physician engagement[03:59] Care access in the future and Walmart “health hubs”[05:55] Health insurance trends and the payor role[08:38] Head winds in the work force[10:18] Redesign and Social Determinants of Health
 
Links | Resources:
Practice and Policy Reset Post-COVID-19 Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

What does transformation look like in the post-pandemic era? – Part 1

The COVID pandemic has transformed all of health care, from the way patients access care to the way clinicians conduct it. In this episode, the first of a two-part series, we will examine how health policies and clinical practice have taken on never-before-seen aspects and where these changes might lead in the future.
 
Guest speaker:Celina BurnsPrincipalFinancial Performance SolutionsVizient
 
Moderator:Tomas Villanueva, DO, MBA, FACPE, SFHMAssociate Vice PresidentClinical ResourcesVizient
 
Show Notes:[00:54] Care moving toward virtual/ambulatory and lower-cost sites[01:53] Changes in financial landscape[02:48] Bringing secrets to light[04:33] Consolidation and mergers; move to regionalized care[05:27] Relieving the pressure[08:06] Value-based payments
 
Links | Resources:
Practice and Policy Reset Post-COVID-19 Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Monoclonal antibody therapy for COVID-19 – Part 3

In Part 3 of this series on monoclonal antibody therapies for COVID-19, our expert panel continues their discussion on concerns about the efficacy and distribution of these treatment options. They respond to the FDA’s recent Emergency Use Authorization (EUA) for monoclonal antibodies.
 
Guest speakers:Azra Behlim, PharmD, MBASenior DirectorPharmacy Sourcing and Program Services Vizient
Stacy Lauderdale, PharmDSenior DirectorDrug InformationVizient
Steve Rudner, PharmD, MSDirectorPharmacy Network ContractingVizient
 
Moderator:Tomas Villanueva, DO, MBA, FACPE, SFHMAssociate Vice PresidentClinical ResourcesVizient
 
Show Notes:[00:37] Identifying the right patients – best practices[03:10] The access challenge[05:54] Plenty of availability[06:10] COVID vaccination and use of monoclonal antibody therapy[06:37] Post-infusion management
 
Links | Resources:
Press release and information from FDA Click here
Information from FDA on EUA for monoclonal antibody therapy Click here
ASPR’s portfolio of COVID-19 medical countermeasures (HHS site) Click here
[ For more information, contact: ASPRstakeholder@HHS.gov ]
JAMA article: “An EUA for Bamlanivimab—A Monoclonal Antiboey for COVID-19” (Dec. 11, 2020) Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Monoclonal antibody therapy for COVID-19 – Part 2

Last November, the FDA released an Emergency Use Authorization (EUA) for the use of monoclonal antibody therapy for adult and pediatric patients with mild to moderate COVID-19. Currently, there is some confusion about the availability and access issues to these treatment options.
 
In this episode, part two of a three-part series, we will address questions and concerns about the distribution and availability of these therapies.
 
Guest speakers:Azra Behlim, PharmD, MBASenior DirectorPharmacy Sourcing and Program Services Vizient
 
Steve Rudner, PharmD, MSDirectorPharmacy Network ContractingVizient
 
Moderator:Tomas Villanueva, DO, MBA, FACPE, SFHMAssociate Vice PresidentClinical ResourcesVizient
 
Show Notes:[02:05] Access to the monoclonal antibody therapies[03:51] No lack of supply[05:07] Infusion options[09:59] Misconceptions and challenges around distribution[11:40] Every idea worth exploring
 
Links | Resources:
Press release and information from FDA Click here
Information from FDA on EUA for monoclonal antibody therapy Click here
ASPR’s portfolio of COVID-19 medical countermeasures (HHS site) Click here
[ For more information, contact: ASPRstakeholder@HHS.gov ]
JAMA article: “An EUA for Bamlanivimab—A Monoclonal Antiboey for COVID-19” (Dec. 11, 2020) Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Monoclonal antibody therapy for COVID-19 – Part 1

COVID-19 vaccines have dominated the headlines. Not garnering the same attention, but just as important, is last November’s US Food and Drug Administration Emergency Use Authorization (EUA) allowing monoclonal antibody therapy for adult and pediatric patients with mild to moderate COVID-19.
 
This episode, beginning a three-part series on this treatment option, will address questions and concerns about the administration of monoclonal antibody therapy.
 
Guest speaker:
Stacy Lauderdale, PharmD
Senior Director
Drug Information
Vizient
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
 
Show Notes:
[01:05] Science behind the treatment
[02:09] Evidence is compelling but hypothesis-generating
[03:43] Choosing an option
[04:37] Role of COVID testing
[04:52] Inclusion and exclusion factors
[06:17] Risk of anaphylaxis
[06:54] Social determinants for treatment
[07:44] Patient risk factors
 
Links | Resources:
Press release and information from FDA Click here
Information from FDA on EUA for monoclonal antibody therapy Click here
ASPR’s portfolio of COVID-19 medical countermeasures (HHS site) Click here
[ For more information, contact: ASPRstakeholder@HHS.gov ]
JAMA article: “An EUA for Bamlanivimab—A Monoclonal Antiboey for COVID-19” (Dec. 11, 2020) Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Advancing team culture: workforce effectiveness during COVID-19 and beyond – Part 3

In this third and final episode of our series on building a team culture, we examine the role of scope of practice, training and fostering a psychologically safe environment to improve and sustain workforce capability.
 
Guest speakers:
Robert Dean, DO, MBA
Senior Vice President
Performance Management
Vizient
 
Katie Davis, RN, MS-HSM
Clinical Workforce Solutions Intelligence Director
Vizient
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
 
Show Notes:
[00:20] Scope of practice and team-based care
[05:59] Core competencies
[08:44] Story from Northwestern Memorial Hospital
[09:38] A new timeline
[09:56] Attributes of a team-based culture
[10:51] The role of virtual health
[11:48] Story from Vidant Health
 
Links | Resources:
Vizient playbook: Advancing team culture for workforce effectiveness Click here
“Disruptive and Toxic Behaviors in Healthcare (Holloway, Kusy) Click here
Leading Frontline COVID-19 Teams: Research-Informed Strategies (Kerrisey, Singer—NEJM Catalyst, September 2020) Click here
What Healthcare Workers Need from Leaders in COVID-19 Crisis (Ratanjee, Foy – Gallup, April 2020) Click here
Diversity Still Matters (Dolan, Hunt, Prince, Sancier-Sultan—McKinsey & Company, May 2020) Click here
“Implementing Optimal Team-Based Care to Reduce Clinician Burnout” (National Academy of Medicine discussion paper – September 17, 2018) Click here
“Association Between Provider Engagement, Staff Engagement, and Culture of Safety” (Journal of Healthcare Quality, July/Aug 2020) Click here
Toxic Workplace!: Managing Toxic Personalities and Their Systems of Power (Kusy, Holloway). Book ordering information: Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed